Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Merck_&_Co.
|
| gptkbp:acquisitionYear |
2004
|
| gptkbp:focus |
oncology
epigenetics |
| gptkbp:foundedIn |
2004
|
| gptkbp:founder |
gptkb:Charles_M._Baum
|
| gptkbp:headquartersLocation |
gptkb:Tarrytown,_New_York,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
Zolinza (vorinostat)
|
| gptkbp:bfsParent |
gptkb:Valeant_Pharmaceuticals
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aton Pharma
|